Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-14

Clinical Trial Update: Mesenchymal Stromal Cells and Osteoarthritis

View source ↗

Summary

The study evaluated mesenchymal stromal cells as a treatment for osteoarthritis and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesenchymal stromal cells

Snippet

Sponsor: Technische Universität Dresden | Conditions: Osteoarthritis | Status: COMPLETED